Average Co-Inventor Count = 4.00
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Esbatech, an Alcon Biomedical Research Unit LLC (5 from 36 patents)
2. Delenex Therapeutics Ag (2 from 5 patents)
3. Cell Medica Switzerland Ag (1 from 5 patents)
4. Esbatech, an Alcon Boimedical Research Unit, LLC (1 from 1 patent)
9 patents:
1. 9683034 - Stable and soluble antibodies inhibiting TNFα
2. 9512411 - Nucleic acid encoding antibodies binding to the extracellular domain of the receptor tyrosine kinase ALK
3. 9315572 - Stable and soluble antibodies inhibiting TNF alpha
4. 8945563 - Method for treating glioblastoma using antibodies binding to the extracellular domain of the receptor tyrosine kinase ALK
5. 8936785 - scFv antibodies which pass epithelial and/or endothelial layers
6. 8691228 - Stable and soluble antibodies inhibiting TNFα
7. 8389693 - Stable and soluble antibodies inhibiting TNFα
8. 8067547 - Stable and soluble antibodies inhibiting TNFα
9. 7902340 - Antibodies binding to the extracellular domain of the receptor tyrosine kinase ALK